Clinical relevance of MGMT in the treatment of cancerGERSON, Stanton L.Journal of clinical oncology. 2002, Vol 20, Num 9, pp 2388-2399, issn 0732-183XArticle

Targeted modulation of MGMT : Clinical implicationsLILI LIU; GERSON, Stanton L.Clinical cancer research. 2006, Vol 12, Num 2, pp 328-331, issn 1078-0432, 4 p.Article

Immunotherapy of cancer with genetically modified tumor vaccinesGILBOA, E.Seminars in oncology. 1996, Vol 23, Num 1, pp 101-107, issn 0093-7754Article

Repopulating defect of mismatch repair-deficient hematopoietic stem cellsREESE, Jane S; LILI LIU; GERSON, Stanton L et al.Blood. 2003, Vol 102, Num 5, pp 1626-1633, issn 0006-4971, 8 p.Article

Gene therapyLATTIME, Edmund C; GERSON, Stanton L.Seminars in oncology. 1996, Vol 23, Num 1, pp 1-197, issn 0093-7754Serial Issue

Measurement of anti-cancer agent methoxyamine in plasma by tandem mass spectrometry with on-line sample extractionSHUMING YANG; LIU, Lili; GERSON, Stanton L et al.Journal of chromatography. B. 2003, Vol 795, Num 2, pp 295-307, issn 1570-0232, 13 p.Article

Chemotherapy-induced O⁶-benzylguanine-resistant alkyltransferase mutations in mismatch-deficient colon cancerLIU, Lili; SCHWARTZ, Stuart; DAVIS, Brian M et al.Cancer research (Baltimore). 2002, Vol 62, Num 11, pp 3070-3076, issn 0008-5472Article

Genomic targeting and genetic conversion in cancer therapyKMIEC, E. B.Seminars in oncology. 1996, Vol 23, Num 1, pp 188-193, issn 0093-7754Article

Tissue specific promoters in targeting systemically delivered gene therapyHART, I. R.Seminars in oncology. 1996, Vol 23, Num 1, pp 154-158, issn 0093-7754Article

Characterization of MLH1 and MSH2 DNA mismatch repair proteins in cell lines of the NCI anticancer drug screenTAVERNA, Pietro; LIU, Lili; HANSON, Amy J et al.Cancer chemotherapy and pharmacology. 2000, Vol 46, Num 6, pp 507-516, issn 0344-5704Article

Novel genetic immunotoxins and intracellular antibodies for cancer therapySI-YI CHEN; MARASCO, W. A.Seminars in oncology. 1996, Vol 23, Num 1, pp 148-153, issn 0093-7754Article

O⁶-benzylguanine and BCNU in multiple myeloma : a phase II trialBATTS, Eric D; MAISEL, Christopher; KANE, Donna et al.Cancer chemotherapy and pharmacology. 2007, Vol 60, Num 3, pp 415-421, issn 0344-5704, 7 p.Article

Methoxyamine potentiates DNA single strand breaks and double strand breaks induced by temozolomide in colon cancer cellsTAVERNA, Pietro; LIU, Lili; HWANG, Hwa-Shin et al.Mutation research. DNA repair. 2001, Vol 485, Num 4, pp 269-281, issn 0921-8777Article

Detection of specific genetic alterations in cancer cellsHUEBNER, K; OHTA, M; LUBINSKI, J et al.Seminars in oncology. 1996, Vol 23, Num 1, pp 22-30, issn 0093-7754Article

Antisense strategies in the treatment of leukemiasCALABRETTA, B; SKORSKI, T; RATAJCZAK, M. Z et al.Seminars in oncology. 1996, Vol 23, Num 1, pp 78-87, issn 0093-7754Article

Differential degradation rates of inactivated alkyltransferase in blood mononuclear cells and tumors of patients after treatment with O⁶-benzylguanineLIU, Lili; SPIRO, Timothy P; XIUSHENG QIN et al.Clinical cancer research. 2001, Vol 7, Num 8, pp 2318-2324, issn 1078-0432Article

p53 gene therapy in vivo of hepatocellular and liver metastatic colorectal cancerBOOKSTEIN, R; DEMERS, W; GREGORY, R et al.Seminars in oncology. 1996, Vol 23, Num 1, pp 66-77, issn 0093-7754Article

Genetic approaches to adoptive cellular therapy of malignancyARCA, M. J; MULE, J. J; CHANG, A. E et al.Seminars in oncology. 1996, Vol 23, Num 1, pp 108-117, issn 0093-7754Article

Parvoviral vectors for the gene therapy of cancerSHAUGHNESSY, E; DI LU; SASWATI CHATTERJEE et al.Seminars in oncology. 1996, Vol 23, Num 1, pp 159-171, issn 0093-7754Article

Phase I trial of fludarabine, bortezomib and rituximab for relapsed and refractory indolent and mantle cell non-Hodgkin lymphomaBARR, Paul M; PINGFU FU; LAZARUS, Hillard M et al.British journal of haematology. 2009, Vol 147, Num 1, pp 89-96, issn 0007-1048, 8 p.Article

Targets of Small Interfering RNA Restriction during Human Immunodeficiency Virus Type 1 ReplicationYONG GAO; LOBRITZ, Michael A; ROTH, Justin et al.Journal of virology. 2008, Vol 82, Num 6, pp 2938-2951, issn 0022-538X, 14 p.Article

Long-term-infected telomerase-immortalized endothelial cells : a model for Kaposi's sarcoma-associated herpesvirus latency in vitro and in vivoAN, Feng-Qi; FOLARIN, Hope Merlene; COMPITELLO, Nicole et al.Journal of virology. 2006, Vol 80, Num 10, pp 4833-4846, issn 0022-538X, 14 p.Article

Phase I and correlative study of combination Bryostatin 1 and vincristine in relapsed B-cell malignanciesDOWLATI, Afshin; LAZARUS, Hillard M; MURGO, Anthony J et al.Clinical cancer research. 2003, Vol 9, Num 16, pp 5929-5935, issn 1078-0432, 7 p., 1Article

Lung tumorigenesis associated with erb-B-2 and erb-B-3 overexpression in human erb-B-3 transgenic mice is enhanced by methylnitrosoureaHANG ZHOU; LILI LIU; KEUNMYOUNG LEE et al.Oncogene (Basingstoke). 2002, Vol 21, Num 57, pp 8732-8740, issn 0950-9232, 9 p.Article

Systemic deficits in transporter for antigen presentation (TAp)-1 or proteasome subunit LMP2 have little or no effect on tumor incidenceJOHNSEN, Alyssa K; FRANCE, John; NAGY, Nancy et al.International journal of cancer. 2001, Vol 91, Num 3, pp 366-372, issn 0020-7136Article